Enoxacin

CAS : 74011-58-8

Ref. 3D-FE22673

Informations sur le produit

• Nom: Enoxacin
• Synonymes: 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acidEnofloxacinEnofloxacine, 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, 1-Ethyl-6-Fluoro-4-Oxo-7-(Piperazin-1-Yl)-1,4-Dihydro-1,8-Naphthyridine-3-Carboxylic Acid, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic Acid, 1-Ethyl-6-fluoro-4-oxo-7-piperazin-4-ium-1-yl-1,8-naphthyridine-3-carboxylate, At 2266, Ci 919, Enofloxacin, Enofloxacine, Enoksetin, Enoxacin (Patent-No-Supply), Enoxacine, Enoxor, Flumark, Nsc 629661, Pd 107779, Penetrex, Penetrex (pharmaceutical)

Description

Enoxacin is a nonsteroidal anti-inflammatory drug that inhibits the production of prostaglandins and thromboxanes. It has been shown to be effective against infectious diseases caused by bacteria, protozoa, and fungi, including E. coli, Salmonella typhimurium, Giardia lamblia, Candida albicans, Trichophyton mentagrophytes, Microsporum canis and T. violaceum. Enoxacin's mechanism of action is not fully understood but it may inhibit the transcription of genes that code for proteins involved in inflammation or produce an inhibitory response element in the promoter region of these genes. This drug also has minimal toxicity to humans and low levels of drug interactions with other drugs when taken concurrently. Nitrite ion and human polymorphonuclear leukocytes (PMNL) are both important factors in enoxacin's mechanism of action as they activate the enzyme guanylate cyclase which

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 320.32 g/mol
• Formule: C₁₅H₁₇FN₄O₃
• Degré de pureté: Min. 95%